Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

Clinical trial NCT06530784 · UNKNOWN

Trial details

NCT number: NCT06530784
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2024-07-31
Primary completion: 2025-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.